ABIMMUNE BIOPHARMA
DEAD

Serial Number

88683760

Owner

Fang Fang

Attorney

Abraham Lichy

Filing Date

Nov 7, 2019

Add to watchlist:

No watchlists yet
View on USPTO

ABIMMUNE BIOPHARMA Trademark

Serial Number: 88683760

ABIMMUNE BIOPHARMA is a trademark filed by Fang Fang on November 7, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Fang Fang (23 trademarks)

PO Box 8793
RANCHO SANTA FE, CA 92067

Entity Type: 01

Trademark Details

Filing Date

November 7, 2019

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations and substances for the treatment of traumas and emergencies, namely, fractures, abrasions, burns, psychological and immunological shock, poison and pollution ingestion, animal bites and stings, fever, respiratory and cardiovascular shock, hemorrhages, bleeding, thrombosis, emboli, stroke, apoplexy, and lesions and cognitive dysfunction, and the treatment of addictions, aging, allergy immunology, burns, diseases of the heart and blood vessels, dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, neurological diseases, nephrological diseases, diseases in the obstetrical and gynecological field, cancer, ophthalmologic diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear-nose and throat, diseases and afflictions of the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions, and occupational diseases and afflictions, namely, cancer, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, cardiac diseases, hepatic diseases, rheumatism, and urological diseases and afflictions

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 9, 2021 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 9, 2021 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 31, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 31, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 31, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 11, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 11, 2020 GNRN
NON-FINAL ACTION E-MAILED
Feb 11, 2020 GNRT
NON-FINAL ACTION WRITTEN
Feb 11, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 11, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2019 NWOS
NEW APPLICATION ENTERED
Nov 11, 2019 NWAP